Patents by Inventor Ping Y. Huang

Ping Y. Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20200157230
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 21, 2020
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • Bispecific binding proteins that bind CD40 and mesothelin
    Patent number: 10233258
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: March 19, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko Akamatsu, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • BISPECIFIC BINDING PROTEINS
    Publication number: 20180194862
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 12, 2018
    Inventors: Yoshiko AKAMATSU, Patricia CULP, Charles M. FORSYTH, Ping Y. HUANG, David POWERS, Alan F. WAHL, Shiming YE
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20180127506
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 10, 2018
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • BISPECIFIC BINDING PROTEINS
    Publication number: 20170342169
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Yoshiko AKAMATSU, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • DAC HYP compositions
    Patent number: 9815903
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: November 14, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS
    Publication number: 20170247461
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 4, 2017
    Publication date: August 31, 2017
    Inventors: Taymar E. HARTMAN, Paul W. SAUER, John E. BURKY, Mark C. WESSON, Ping Y. HUANG, Thomas J. ROBINSON, Braeden D. PARTRIDGE, J. Yun TSO
  • DAC HYP compositions and methods
    Patent number: 9676860
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: June 13, 2017
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP compositions and methods
    Patent number: 9340619
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: May 17, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP compositions and methods
    Patent number: 9260528
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: February 16, 2016
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Taymar E. Hartman, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150274832
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: June 9, 2015
    Publication date: October 1, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150203583
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: January 21, 2015
    Publication date: July 23, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20150197573
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: March 27, 2015
    Publication date: July 16, 2015
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden D. Partridge, J. Yun Tso
  • DAC HYP COMPOSITIONS AND METHODS
    Publication number: 20120301429
    Abstract: The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
    Type: Application
    Filed: May 25, 2012
    Publication date: November 29, 2012
    Inventors: Taymar E. HARTMAN, Paul W. Sauer, John E. Burky, Mark C. Wesson, Ping Y. Huang, Thomas J. Robinson, Braeden Partridge, J. Yun Tso
  • Direct immunoassay using pH-sensitive fluorochromes
    Patent number: 5334537
    Abstract: The complexing of an antibody-antigen binding pair is determined by observing the change in fluorescence of a pH-sensitive fluorochrome attached to one of the members of the binding pair. When the binding is conducted in a solution having a pH other than the isoelectric point of the antibody, there will be a change in the pH of the microenviromnent surrounding the fluorochrome. This change will correspond to a change in the observed fluorescent intensity. Either member of the binding pair can be labeled, and combined with that member whose presence is suspect, in an immunoassay.
    Type: Grant
    Filed: November 14, 1991
    Date of Patent: August 2, 1994
    Assignee: The University of Maryland
    Inventors: Cheng S. Lee, Ping Y. Huang